| Unique ID issued by UMIN | UMIN000061146 |
|---|---|
| Receipt number | R000069871 |
| Scientific Title | Association between equol production status and lumbar degenerative spondylolisthesis in postmenopausal women |
| Date of disclosure of the study information | 2026/04/04 |
| Last modified on | 2026/04/03 10:27:30 |
Association between equol production status and lumbar degenerative spondylolisthesis in postmenopausal women
Association between equol production status and lumbar degenerative spondylolisthesis in postmenopausal women
Association between equol production status and lumbar degenerative spondylolisthesis in postmenopausal women
Association between equol production status and lumbar degenerative spondylolisthesis in postmenopausal women
| Japan |
lumbar degenerative spondylolisthesis
| Orthopedics |
Others
NO
To investigate the association between lumbar degenerative spondylolisthesis status and equol-producing ability in postmenopausal women
Others
To identify factors associated with lumbar degenerative spondylolisthesis, excluding urinary equol concentration
Exploratory
urinary equol concentration
Demographic and clinical variables, including age at the time of urinary equol measurement, sex, height, weight, body mass index (BMI), medical history, medication use, parity, age at menopause, frequency of soy intake, and bone mineral density.
Observational
| 50 | years-old | <= |
| 65 | years-old | > |
Female
Lumbar degenerative spondylolisthesis group:
Female patients aged 50 to 64 years with imaging-confirmed lumbar degenerative spondylolisthesis
Control group:
Women aged 50 to 64 years who underwent equol testing through the Healthcare Systems service, consented to use of their results for research, had no low back pain, and no prior diagnosis of lumbar spondylolisthesis
Lumbar degenerative spondylolisthesis group:
History of hormone therapy, equol supplement use (within 3 months), vertebral fracture or spondylolysis history, antibiotic use (within 2 weeks), heavy lifting occupation, soy allergy, severe hepatic or renal dysfunction, dialysis, rheumatoid arthritis, inflammatory spondylitis or DISH, and investigator-determined ineligibility
Control group:
History of lumbar spine surgery, hormone therapy, equol supplement use (within 3 months), vertebral fracture or spondylolysis history, antibiotic use (within 2 weeks), heavy lifting occupation, soy allergy, severe hepatic or renal dysfunction, dialysis, rheumatoid arthritis, inflammatory spondylitis or DISH, and investigator-determined ineligibility
200
| 1st name | Takashi |
| Middle name | |
| Last name | Hirai |
Institute of Science Tokyo
Department of Orthopaedic and Spinal Surgery
113-8510
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
0358035678
hirai.orth@tmd.ac.jp
| 1st name | Miyamoto |
| Middle name | |
| Last name | Reina |
Institute of Science Tokyo
Department of Orthopaedic and Spinal Surgery, Graduate School of Medical and Dental Sciences, Instit
113-8510
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
03-5803-5279
miyamoto.r.d077@m.isct.ac.jp
Institute of Science Tokyo
Institute of Science Tokyo
Self funding
Bioethics Group, Research Infrastructure Division, Research Promotion Department
1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
03-5803-4547
rinri.adm@tmd.ac.jp
NO
| 2026 | Year | 04 | Month | 04 | Day |
Unpublished
Preinitiation
| 2026 | Year | 04 | Month | 01 | Day |
| 2026 | Year | 05 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
Currently under ethical review
| 2026 | Year | 04 | Month | 03 | Day |
| 2026 | Year | 04 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069871